Disposition of 110 shares by Deck Kelly of InhibrxInc at 10.52 subject to Rule 16b-3
INBX Stock | USD 14.23 0.24 1.66% |
Slightly above 52% of Inhibrx's investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Inhibrx suggests that some traders are interested. Inhibrx's investing sentiment can be driven by a variety of factors including economic data, Inhibrx's earnings reports, geopolitical events, and overall market trends.
Inhibrx |
Filed transaction by InhibrxInc Officer: Chief Financial Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
Cash Flow Correlation
Inhibrx's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Inhibrx's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Inhibrx Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Inhibrx can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Inhibrx Fundamental Analysis
We analyze Inhibrx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Inhibrx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Inhibrx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
Inhibrx is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Inhibrx Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Inhibrx stock to make a market-neutral strategy. Peer analysis of Inhibrx could also be used in its relative valuation, which is a method of valuing Inhibrx by comparing valuation metrics with similar companies.
Peers
Inhibrx Related Equities
RCUS | Arcus Biosciences | 2.90 | ||||
CRBU | Caribou Biosciences | 0.00 | ||||
FATE | Fate Therapeutics | 1.79 | ||||
KPTI | Karyopharm Therapeutics | 7.03 | ||||
XFOR | X4 Pharmaceuticals | 8.11 | ||||
HOOK | Hookipa Pharma | 9.41 |
Additional Tools for Inhibrx Stock Analysis
When running Inhibrx's price analysis, check to measure Inhibrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibrx is operating at the current time. Most of Inhibrx's value examination focuses on studying past and present price action to predict the probability of Inhibrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inhibrx's price. Additionally, you may evaluate how the addition of Inhibrx to your portfolios can decrease your overall portfolio volatility.